Corrigendum: Interferon-induced transmembrane protein 3 in the hippocampus: a potential novel target for the therapeutic effects of recombinant human brain natriuretic peptide on sepsis-associated encephalopathy
Nan Li1,2† Rui-Hang Ma1† Er-Fei Zhang2,3† Feng Ge1 De-Yu Fang4 Jing Zhang5 Yan-Ning Zhang6 Yan Gao1 Li-Chao Hou2,7* 
Hong-Xu Jin1*- 1Department of Emergency Medicine, General Hospital of Northern Theater Command, Shenyang, Liaoning, China
- 2Department of Anesthesiology and Critical Care Medicine, Xijing Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, China
- 3Department of Anesthesiology, The Affiliated Hospital of Yan'an University, Yan'an, Shaanxi, China
- 4Department of Chemistry, Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning, China
- 5Department of Intensive Care Unit, Yue Bei People's Hospital, The Affiliated Hospital of Shantou University, Shaoguan, Guangdong, China
- 6Department of Nephrology, General Hospital of Northern Theater Command, Shenyang, China
- 7Department of Anesthesiology, Xiang'an Hospital of Xiamen University, Xiamen, Fujian, China
by Li, N., Ma, R.-H., Zhang, E.-F., Ge, F., Fang, D.-Y., Zhang, J., Zhang, Y.-N., Gao, Y., Hou, L.-C., and Jin, H.-X. (2023). Front. Mol. Neurosci. 16:1182005. doi: 10.3389/fnmol.2023.1182005
In the published article, there was an error in the order of the corresponding authors. Instead of “Li-Chao Hou, houlichaohlc6@126.com; Hong-Xu Jin, jinhongxunjhx8@126.com”, it should be in the correct order of “Hong-Xu Jin, jinhongxunjhx8@126.com; Li-Chao Hou, houlichaohlc6@126.com”. We should also state Hong-Xu Jin is responsible for the integrity of the work as a whole. Li-Chao Hou contributes equally to this study as common corresponding author.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: sepsis-associated encephalopathy (SAE), recombinant human brain natriuretic peptide (rhBNP), interferon-induced transmembrane protein 3 (IFITM3), inflammation, apoptosis
Citation: Li N, Ma R-H, Zhang E-F, Ge F, Fang D-Y, Zhang J, Zhang Y-N, Gao Y, Hou L-C and Jin H-X (2023) Corrigendum: Interferon-induced transmembrane protein 3 in the hippocampus: a potential novel target for the therapeutic effects of recombinant human brain natriuretic peptide on sepsis-associated encephalopathy. Front. Mol. Neurosci. 16:1294087. doi: 10.3389/fnmol.2023.1294087
Received: 14 September 2023; Accepted: 15 September 2023;
Published: 27 September 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Li, Ma, Zhang, Ge, Fang, Zhang, Zhang, Gao, Hou and Jin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Hong-Xu Jin, jinhongxunjhx8@126.com; Li-Chao Hou, houlichaohlc6@126.com
†These authors have contributed equally to this work